TipRanks
Xenon (MX:XENEN)
:XENEN
Mexico Market
XENEN
Xenon
RESEARCH TOOLSreports

Xenon (XENEN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

XENEN Analyst Ratings

Strong Buy
16Ratings
Strong Buy
15 Buy
1 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Xenon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XENEN Stock 12 Month Forecast

Average Price Target

―
Based on 16 Wall Street analysts offering 12 month price targets for Xenon in the last 3 months. The average price target is $1,292.31 with a high forecast of $1,628.58 and a low forecast of $832.38. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$1,629Average Price Target$1,292Lowest Price Target$832.38
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on MX:XENEN
Brian Abrahams
RBC Capital
RBC Capital
$1,266.67
Buy
―
Reiterated
10/01/26
RBC Capital Sticks to Its Buy Rating for Xenon (XENE)
Bloom Burton Analyst forecast on MX:XENEN
David Martin PhD
Bloom Burton
Bloom Burton
$1,339.05→$1,284.77
Buy
―
Reiterated
09/21/26
Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), Xenon (NASDAQ: XENE) and AnaptysBio (NASDAQ: ANAB)
J.P. Morgan Analyst forecast on MX:XENEN
Tessa Romero
J.P. Morgan
J.P. Morgan
$1,483.81
Buy
―
Reiterated
09/19/26
J.P. Morgan Sticks to Its Buy Rating for Xenon (XENE)
Bank of America Securities Analyst forecast on MX:XENEN
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)
William Blair Analyst forecast on MX:XENEN
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
09/18/26
Minter Reiterates Buy on Xenon as Azetukalner NDA Progress and Manageable Neuropsychiatric Risk Underscore Favorable Risk‑Reward
H.C. Wainwright Analyst forecast on MX:XENEN
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,339.05
Buy
―
Reiterated
09/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aethlon Medical (NASDAQ: AEMD), Xenon (NASDAQ: XENE) and Oculis Holding (NASDAQ: OCS)
TD Cowen Analyst forecast on MX:XENEN
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/18/26
Xenon selloff on enrollment pause overdone, says TD CowenXenon selloff on enrollment pause overdone, says TD Cowen
Wedbush Analyst forecast on MX:XENEN
Laura Chico
Wedbush
Wedbush
$1,284.77→$995.24
Buy
―
Reiterated
09/18/26
Wedbush Sticks to Its Buy Rating for Xenon (XENE)
Deutsche Bank Analyst forecast on MX:XENEN
David Hoang
Deutsche Bank
Deutsche Bank
$1,628.58→$832.38
Hold
―
Downgraded
09/18/26
Xenon Pharmaceuticals downgraded to Hold from Buy at Deutsche BankXenon Pharmaceuticals downgraded to Hold from Buy at Deutsche Bank
Needham Analyst forecast on MX:XENEN
Serge Belanger
Needham
Needham
$1,411.43→$1,085.72
Buy
―
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), IDEAYA Biosciences (IDYA)
Stifel Nicolaus Analyst forecast on MX:XENEN
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
―
Buy
―
Reiterated
09/18/26
Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and Envista Holdings (NYSE: NVST)
Wells Fargo Analyst forecast on MX:XENEN
Benjamin Burnett
Wells Fargo
Wells Fargo
$1,248.57→$1,158.1
Buy
―
Reiterated
09/18/26
Xenon Pharmaceuticals price target lowered to $64 from $69 at Wells FargoXenon Pharmaceuticals price target lowered to $64 from $69 at Wells Fargo
Robert W. Baird Analyst forecast on MX:XENEN
Brian Skorney
Robert W. Baird
Robert W. Baird
$1,755.24→$1,628.58
Buy
―
Reiterated
09/18/26
Xenon Pharmaceuticals price target lowered to $90 from $97 at BairdXenon Pharmaceuticals price target lowered to $90 from $97 at Baird
Goldman Sachs Analyst forecast on MX:XENEN
Paul Choi
Goldman Sachs
Goldman Sachs
$1,357.15
Buy
―
Reiterated
09/17/26
Goldman Sachs Sticks to Its Buy Rating for Xenon (XENE)
Evercore ISI Analyst forecast on MX:XENEN
Cory Kasimov
Evercore ISI
Evercore ISI
$1,447.62
Buy
―
Reiterated
08/07/26
Evercore ISI Reaffirms Their Buy Rating on Xenon (XENE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on MX:XENEN
Brian Abrahams
RBC Capital
RBC Capital
$1,266.67
Buy
―
Reiterated
10/01/26
RBC Capital Sticks to Its Buy Rating for Xenon (XENE)
Bloom Burton Analyst forecast on MX:XENEN
David Martin PhD
Bloom Burton
Bloom Burton
$1,339.05→$1,284.77
Buy
―
Reiterated
09/21/26
Analysts Conflicted on These Healthcare Names: Alcon (NYSE: ALC), Xenon (NASDAQ: XENE) and AnaptysBio (NASDAQ: ANAB)
J.P. Morgan Analyst forecast on MX:XENEN
Tessa Romero
J.P. Morgan
J.P. Morgan
$1,483.81
Buy
―
Reiterated
09/19/26
J.P. Morgan Sticks to Its Buy Rating for Xenon (XENE)
Bank of America Securities Analyst forecast on MX:XENEN
Jason Gerberry
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)
William Blair Analyst forecast on MX:XENEN
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
09/18/26
Minter Reiterates Buy on Xenon as Azetukalner NDA Progress and Manageable Neuropsychiatric Risk Underscore Favorable Risk‑Reward
H.C. Wainwright Analyst forecast on MX:XENEN
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,339.05
Buy
―
Reiterated
09/18/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aethlon Medical (NASDAQ: AEMD), Xenon (NASDAQ: XENE) and Oculis Holding (NASDAQ: OCS)
TD Cowen Analyst forecast on MX:XENEN
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
09/18/26
Xenon selloff on enrollment pause overdone, says TD CowenXenon selloff on enrollment pause overdone, says TD Cowen
Wedbush Analyst forecast on MX:XENEN
Laura Chico
Wedbush
Wedbush
$1,284.77→$995.24
Buy
―
Reiterated
09/18/26
Wedbush Sticks to Its Buy Rating for Xenon (XENE)
Deutsche Bank Analyst forecast on MX:XENEN
David Hoang
Deutsche Bank
Deutsche Bank
$1,628.58→$832.38
Hold
―
Downgraded
09/18/26
Xenon Pharmaceuticals downgraded to Hold from Buy at Deutsche BankXenon Pharmaceuticals downgraded to Hold from Buy at Deutsche Bank
Needham Analyst forecast on MX:XENEN
Serge Belanger
Needham
Needham
$1,411.43→$1,085.72
Buy
―
Reiterated
09/18/26
Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), IDEAYA Biosciences (IDYA)
Stifel Nicolaus Analyst forecast on MX:XENEN
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
―
Buy
―
Reiterated
09/18/26
Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and Envista Holdings (NYSE: NVST)
Wells Fargo Analyst forecast on MX:XENEN
Benjamin Burnett
Wells Fargo
Wells Fargo
$1,248.57→$1,158.1
Buy
―
Reiterated
09/18/26
Xenon Pharmaceuticals price target lowered to $64 from $69 at Wells FargoXenon Pharmaceuticals price target lowered to $64 from $69 at Wells Fargo
Robert W. Baird Analyst forecast on MX:XENEN
Brian Skorney
Robert W. Baird
Robert W. Baird
$1,755.24→$1,628.58
Buy
―
Reiterated
09/18/26
Xenon Pharmaceuticals price target lowered to $90 from $97 at BairdXenon Pharmaceuticals price target lowered to $90 from $97 at Baird
Goldman Sachs Analyst forecast on MX:XENEN
Paul Choi
Goldman Sachs
Goldman Sachs
$1,357.15
Buy
―
Reiterated
09/17/26
Goldman Sachs Sticks to Its Buy Rating for Xenon (XENE)
Evercore ISI Analyst forecast on MX:XENEN
Cory Kasimov
Evercore ISI
Evercore ISI
$1,447.62
Buy
―
Reiterated
08/07/26
Evercore ISI Reaffirms Their Buy Rating on Xenon (XENE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
WSTWest Pharmaceutical Services
ZYMEZymeworks
SLDBSolid Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xenon

3 Months
Serge BelangerNeedham
Success Rate
15/24 ratings generated profit
63%
Average Return
+8.10%
Copying Serge Belanger's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +8.10% per trade.
1 Year
Andrew TsaiJefferies
Success Rate
14/18 ratings generated profit
78%
Average Return
+33.03%
Copying Andrew Tsai's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +33.03% per trade.
2 Years
Andrew TsaiJefferies
Success Rate
13/18 ratings generated profit
72%
Average Return
+35.21%
Copying Andrew Tsai's trades and holding each position for 2 Years would result in 72.22% of your transactions generating a profit, with an average return of +35.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XENEN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
2
0
6
7
Buy
14
12
13
20
20
Hold
0
0
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
14
13
27
28
In the current month, XENEN has received 27 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. XENEN average Analyst price target in the past 3 months is 1,292.31.
Each month's total comprises the sum of three months' worth of ratings.

XENEN Financial Forecast

XENEN Earnings Forecast

Next quarter’s earnings estimate for XENEN is -$20.50 with a range of -$23.34 to -$17.01. The previous quarter’s EPS was -$20.09. XENEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year XENEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for XENEN is -$20.50 with a range of -$23.34 to -$17.01. The previous quarter’s EPS was -$20.09. XENEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year XENEN has Performed in-line its overall industry.

XENEN Sales Forecast

Next quarter’s sales forecast for XENEN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. XENEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year XENEN has Performed in-line its overall industry.
Next quarter’s sales forecast for XENEN is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. XENEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year XENEN has Performed in-line its overall industry.

XENEN Stock Forecast FAQ

What is MX:XENEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Xenon’s 12-month average price target is 1,292.31.
    What is MX:XENEN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:XENEN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Xenon a Buy, Sell or Hold?
        Xenon has a consensus rating of Strong Buy, which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Xenon’s share price target?
          The average share price target for Xenon is 1,292.31. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $1,628.58 ,and the lowest forecast is $832.38. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Xenon?
            Xenon’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of Xenon?
              To buy shares of MX:XENEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.